FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alain Couvineau

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Concepts & Ideas

Genes & Molecular Sequences

Amino Acid Sequences

Physiology

Phenomena

Protein Binding

Co-author Network

Publications

TOP 3
Alain Couvineau; Emilie Ceraudo; Yossan-Var Tan; Marc Laburthe
Strategies for studying the ligand binding site of GPCRs: photoaffinity labeling of the VPAC1 receptor, a prototype of class B GPCRs.
Laurent Intes; Pascal Nicole; Muriel Bahut; Alain Couvineau; Catherine Guette; Alphonse Calenda
Intestinal cell targeting of a stable recombinant Cu-Zn SOD from Cucumis melo fused to a gliadin peptide.
Emilie Ceraudo; Régine Hierso; Nadège Jamin; Marc Laburthe; Samuel Murail; Jean-Michel Neumann; Pascal Nicole; Patrick Robberecht; Jean-Claude Robert; Christiane Rouyer-Fessard; Yossan-Var Tan; Alain Couvineau
Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alain Couvineau (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Alain Couvineau; Emilie Ceraudo; Yossan-Var Tan; Marc Laburthe
Strategies for studying the ligand binding site of GPCRs: photoaffinity labeling of the VPAC1 receptor, a prototype of class B GPCRs.
Methods in enzymology 2013;520():219-37.
2012: Laurent Intes; Pascal Nicole; Muriel Bahut; Alain Couvineau; Catherine Guette; Alphonse Calenda
Intestinal cell targeting of a stable recombinant Cu-Zn SOD from Cucumis melo fused to a gliadin peptide.
Journal of biotechnology 2012;159(1-2):99-107.
2012: Emilie Ceraudo; Régine Hierso; Nadège Jamin; Marc Laburthe; Samuel Murail; Jean-Michel Neumann; Pascal Nicole; Patrick Robberecht; Jean-Claude Robert; Christiane Rouyer-Fessard; Yossan-Var Tan; Alain Couvineau
Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2012;26(5):2060-71.
2012: Alain Couvineau; Marc Laburthe
VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins.
British journal of pharmacology 2012;166(1):42-50.
2012: Alain Couvineau; Pascal Nicole; Yossan-Var Tan; Emilie Ceraudo; Marc Laburthe
The VPAC1 receptor: structure and function of a class B GPCR prototype.
Frontiers in endocrinology 2012;3():139.
2012: Alain Couvineau; Marc Laburthe
The family B1 GPCR: structural aspects and interaction with accessory proteins.
Current drug targets 2012;13(1):103-15.
2011: Agnès Linglart; Christine Menguy; Emmanuelle Motte; Graziella Pinto; Colette Auzan; Pierre Bougnères; Mathilde Cancel; Philippe Chanson; Eric Clauser; Alain Couvineau; Yasemin Gunes; Caroline Silve
Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance.
The New England journal of medicine 2011;364(23):2218-26.
2011: Agnieszka Dejda; Steve Bourgault; Ngoc Duc Doan; Myriam Létourneau; Alain Couvineau; Hubert Vaudry; David Vaudry; Alain Fournier
Identification by photoaffinity labeling of the extracellular N-terminal domain of PAC1 receptor as the major binding site for PACAP.
Biochimie 2011;93(4):669-77.
2010: Kévin Darbandi-Tehrani; Patricia Hermand; Stéphanie Carvalho; Karim Dorgham; Alain Couvineau; Jean-Jacques Lacapère; Christophe Combadière; Philippe Deterre
Subtle conformational changes between CX3CR1 genetic variants as revealed by resonance energy transfer assays.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2010;24(11):4585-98.
2010: Alain Couvineau; Emilie Ceraudo; Yossan-Var Tan; Marc Laburthe
VPAC1 receptor binding site: contribution of photoaffinity labeling approach.
Neuropeptides 2010;44(2):127-32.
2009: Aadil El Firar; Thierry Voisin; Christiane Rouyer-Fessard; Mariano A Ostuni; Alain Couvineau; Marc Laburthe
Discovery of a functional immunoreceptor tyrosine-based switch motif in a 7-transmembrane-spanning receptor: role in the orexin receptor OX1R-driven apoptosis.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2009;23(12):4069-80.
2009: Steve Bourgault; David Vaudry; Isabelle Ségalas-Milazzo; Laure Guilhaudis; Alain Couvineau; Marc Laburthe; Hubert Vaudry; Alain Fournier
Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor.
Journal of medicinal chemistry 2009;52(10):3308-16.
2008: Emilie Ceraudo; Yossan-Var Tan; Pascal Nicole; Alain Couvineau; Marc Laburthe
The N-terminal parts of VIP and antagonist PG97-269 physically interact with different regions of the human VPAC1 receptor.
Journal of molecular neuroscience : MN 2008;36(1-3):245-8.
2008: Alain Couvineau; Jean-Claude Robert; Tarik Ramdani; Jean-Jacques Lacapère; Christiane Rouyer-Fessard; Marc Laburthe
Production and purification of large quantities of the functional N-terminal ectodomain of human VPAC1 receptor.
Journal of molecular neuroscience : MN 2008;36(1-3):249-53.
2008: Steve Bourgault; David Vaudry; Laure Guilhaudis; Emilie Raoult; Alain Couvineau; Marc Laburthe; Isabelle Ségalas-Milazzo; Hubert Vaudry; Alain Fournier
Biological and structural analysis of truncated analogs of PACAP27.
Journal of molecular neuroscience : MN 2008;36(1-3):260-9.
2008: Nicolas Aubert; David Vaudry; Anthony Falluel-Morel; Arnaud Desfeux; Cecile Fisch; Philippe Ancian; Stéphane De Jouffrey; Jean-François Le Bigot; Alain Couvineau; Marc Laburthe; Alain Fournier; Vincent Laudenbach; Hubert Vaudry; Bruno J Gonzalez
PACAP prevents toxicity induced by cisplatin in rat and primate neurons but not in proliferating ovary cells: involvement of the mitochondrial apoptotic pathway.
Neurobiology of disease 2008;32(1):66-80.
2008: Alain Couvineau; Vinciane Wouters; Guylène Bertrand; Christiane Rouyer; Bénédicte Gérard; Laurence M Boon; Bernard Grandchamp; Miikka Vikkula; Caroline Silve
PTHR1 mutations associated with Ollier disease result in receptor loss of function.
Human molecular genetics 2008;17(18):2766-75.
2008: Jean-Michel Neumann; Alain Couvineau; Samuel Murail; Jean-Jacques Lacapère; Nadège Jamin; Marc Laburthe
Class-B GPCR activation: is ligand helix-capping the key?
Trends in biochemical sciences 2008;33(7):314-9.
2008: Steve Bourgault; David Vaudry; Béatrice Botia; Alain Couvineau; Marc Laburthe; Hubert Vaudry; Alain Fournier
Novel stable PACAP analogs with potent activity towards the PAC1 receptor.
Peptides 2008;29(6):919-32.
2008: Emilie Ceraudo; Samuel Murail; Yossan-Var Tan; Jean-Jacques Lacapère; Jean-Michel Neumann; Alain Couvineau; Marc Laburthe
The vasoactive intestinal peptide (VIP) alpha-Helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/Pituitary adenylate cyclase-activating peptide 1 receptor: photoaffinity, molecular modeling, and dynamics.
Molecular endocrinology (Baltimore, Md.) 2008;22(1):147-55.
2007: Geraldine Favrais; Alain Couvineau; Marc Laburthe; Pierre Gressens; Vincent Lelievre
Involvement of VIP and PACAP in neonatal brain lesions generated by a combined excitotoxic/inflammatory challenge.
Peptides 2007;28(9):1727-37.
2007: Marc Laburthe; Alain Couvineau; Var Tan
Class II G protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology.
Peptides 2007;28(9):1631-9.
2006: Yossan-Var Tan; Alain Couvineau; Jean-Jacques Lacapere; Marc Laburthe
Characterization of the new photoaffinity probe (Bz2-K24)-VIP.
Annals of the New York Academy of Sciences 2006;1070():575-80.
2006: Colin Debaigt; Annie-Claire Meunier; Stéphanie Goursaud; Alicia Montoni; Nicolas Pineau; Alain Couvineau; Marc Laburthe; Jean-Marc MULLER; Thierry Janet
Expression and GTP sensitivity of peptide histidine isoleucine high-affinity-binding sites in rat.
Annals of the New York Academy of Sciences 2006;1070():215-9.
2006: Alain Couvineau; Yossan-Var Tan; Emilie Ceraudo; Jean-Jacques Lacapère; Samuel Murail; Jean-Michel Neumann; Marc Laburthe
The human VPAC1 receptor: identification of the N-terminal ectodomain as a major VIP-binding site by photoaffinity labeling and 3D modeling.
Annals of the New York Academy of Sciences 2006;1070():205-9.
2006: Emilie Ceraudo; Yossan-Var Tan; Alain Couvineau; Jean-Jacques Lacapere; Marc Laburthe
Spatial approximation between the C-terminus of VIP and the N-terminal ectodomain of the VPAC1 receptor.
Annals of the New York Academy of Sciences 2006;1070():180-4.
2006: Yossan-Var Tan; Alain Couvineau; Samuel Murail; Emilie Ceraudo; Jean-Michel Neumann; Jean-Jacques Lacapère; Marc Laburthe
Peptide agonist docking in the N-terminal ectodomain of a class II G protein-coupled receptor, the VPAC1 receptor. Photoaffinity, NMR, and molecular modeling.
The Journal of biological chemistry 2006;281(18):12792-8.
2004: Alain Couvineau; Christiane Rouyer-Fessard; Marc Laburthe
Presence of a N-terminal signal peptide in class II G protein-coupled receptors: crucial role for expression of the human VPAC1 receptor.
Regulatory peptides 2004;123(1-3):181-5.
2004: Yossan-Var Tan; Alain Couvineau; Marc Laburthe
Diffuse pharmacophoric domains of vasoactive intestinal peptide (VIP) and further insights into the interaction of VIP with the N-terminal ectodomain of human VPAC1 receptor by photoaffinity labeling with [Bpa6]-VIP.
The Journal of biological chemistry 2004;279(37):38889-94.
2003: Jean-Claude Marie; Christiane Rouyer-Fessard; Alain Couvineau; Pascal Nicole; Hélène Devaud; Jamel El Benna; Marc Laburthe
Serine 447 in the carboxyl tail of human VPAC1 receptor is crucial for agonist-induced desensitization but not internalization of the receptor.
Molecular pharmacology 2003;64(6):1565-74.
2003: Yossan-Var Tan; Alain Couvineau; Jean Van Rampelbergh; Marc Laburthe
Photoaffinity labeling demonstrates physical contact between vasoactive intestinal peptide and the N-terminal ectodomain of the human VPAC1 receptor.
The Journal of biological chemistry 2003;278(38):36531-6.
2003: Alain Couvineau; Jean-Jacques Lacapere; Yossan-Var Tan; Christiane Rouyer-Fessard; Pascal Nicole; Marc Laburthe
Identification of cytoplasmic domains of hVPAC1 receptor required for activation of adenylyl cyclase. Crucial role of two charged amino acids strictly conserved in class II G protein-coupled receptors.
The Journal of biological chemistry 2003;278(27):24759-66.
2003: Arthur Christopoulos; George Christopoulos; Maria Morfis; Madhara Udawela; Marc Laburthe; Alain Couvineau; Kenji Kuwasako; Nanda Tilakaratne; Patrick M Sexton
Novel receptor partners and function of receptor activity-modifying proteins.
The Journal of biological chemistry 2003;278(5):3293-7.
2002: Marc Laburthe; Alain Couvineau
Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP.
Regulatory peptides 2002;108(2-3):165-73.
2002: Kai Du; Alain Couvineau; Christiane Rouyer-Fessard; Pascal Nicole; Marc Laburthe
Human VPAC1 receptor selectivity filter. Identification of a critical domain for restricting secretin binding.
The Journal of biological chemistry 2002;277(40):37016-22.
2002: Marc Laburthe; Alain Couvineau; Jean-Claude Marie
VPAC receptors for VIP and PACAP.
Receptors & channels 2002;8(3-4):137-53.
2001: laurence lins; Alain Couvineau; Christiane Rouyer-Fessard; Pascal Nicole; JJ Maoret; M Benhamed; R Brasseur; Annick Thomas; Marc Laburthe
The human VPAC1 receptor: three-dimensional model and mutagenesis of the N-terminal domain.
The Journal of biological chemistry 2001;276(13):10153-60.
2000: Pascal Nicole; JJ Maoret; Alain Couvineau; F A Momany; Marc Laburthe
Tryptophan 67 in the human VPAC(1) receptor: crucial role for VIP binding.
Biochemical and biophysical research communications 2000;276(2):654-9.
2000: Pascal Nicole; laurence lins; Christiane Rouyer-Fessard; C Drouot; Pierre Fulcrand; Annick Thomas; Alain Couvineau; Jean Martinez; R Brasseur; Marc Laburthe
Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist. Alanine scanning and molecular modeling of the peptide.
The Journal of biological chemistry 2000;275(31):24003-12.
2000: Alain Couvineau; JJ Maoret; Christiane Rouyer-Fessard; I Carrero; Marc Laburthe
The human vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor 1 (VPAC1) promoter: characterization and role in receptor expression during enterocytic differentiation of the colon cancer cell line Caco-2Cl.20.
The Biochemical journal 2000;347 Pt 3():623-32.
2000: Pascal Nicole; Christiane Rouyer-Fessard; Alain Couvineau; C Drouot; Pierre Fulcrand; Jean Martinez; Marc Laburthe
Alanine scanning of VIP. Structure-function relationship for binding to human recombinant VPAC1 receptor.
Annals of the New York Academy of Sciences 2000;921():352-6.
1999: P Gaudin; Alain Couvineau; Christiane Rouyer-Fessard; JJ Maoret; Marc Laburthe
The human vasoactive intestinal Peptide/Pituitary adenylate cyclase activating peptide receptor 1 (VPAC1): constitutive activation by mutations at threonine 343.
Biochemical and biophysical research communications 1999;254(1):15-20.
1998: Kai Du; Pascal Nicole; Alain Couvineau; Marc Laburthe
Construction of chimeras between human VIP1 and secretin receptors: identification of receptor domains involved in selectivity towards VIP, secretin, and PACAP.
Annals of the New York Academy of Sciences 1998;865():386-9.
1998: P Gaudin; Christiane Rouyer-Fessard; Alain Couvineau; JJ Maoret; Marc Laburthe
Constitutive activation of the human VIP1 receptor.
Annals of the New York Academy of Sciences 1998;865():382-5.
1998: Pascal Nicole; Kai Du; Alain Couvineau; Marc Laburthe
Site-directed mutagenesis of human VIP1 versus VIP2 receptors.
Annals of the New York Academy of Sciences 1998;865():378-81.
1998: Alain Couvineau; JJ Maoret; Christiane Rouyer-Fessard; I Carrero; Marc Laburthe
Cloning and functional characterization of the human VIP1/PACAP receptor promoter.
Annals of the New York Academy of Sciences 1998;865():59-63.
1998: P Gaudin; JJ Maoret; Alain Couvineau; Christiane Rouyer-Fessard; Marc Laburthe
Constitutive activation of the human vasoactive intestinal peptide 1 receptor, a member of the new class II family of G protein-coupled receptors.
The Journal of biological chemistry 1998;273(9):4990-6.
1998: Pascal Nicole; Kai Du; Alain Couvineau; Marc Laburthe
Site-directed mutagenesis of human vasoactive intestinal peptide receptor subtypes VIP1 and VIP2: evidence for difference in the structure-function relationship.
The Journal of pharmacology and experimental therapeutics 1998;284(2):744-50.
1997: Kai Du; Pascal Nicole; Alain Couvineau; Marc Laburthe
Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production.
Biochemical and biophysical research communications 1997;230(2):289-92.
1997: Pascal Nicole; Kai Du; Alain Couvineau; Marc Laburthe
[Directed mutagenesis of human recombinant receptors of vasoactive intestinal peptide of VIP1 and VIP2 type. Difference in structure-activity relationship].
Gastroentérologie clinique et biologique 1997;21(5):365-9.
1996: P Gaudin; Alain Couvineau; JJ Maoret; Christiane Rouyer-Fessard; Marc Laburthe
Role of cysteine residues in the N-terminal extracellular domain of the human VIP 1 receptor for ligand binding. A site-directed mutagenesis study.
Annals of the New York Academy of Sciences 1996;805():585-9.
1996: P Gaudin; Alain Couvineau; JJ Maoret; Christiane Rouyer-Fessard; Marc Laburthe
Establishment of a CHO cell clone stably expressing the recombinant human VIP-1 receptor.
Annals of the New York Academy of Sciences 1996;805():570-3.
1996: Alain Couvineau; C Fabre; P Gaudin; JJ Maoret; Marc Laburthe
Mutagenesis of N-glycosylation sites in the human VIP 1 receptor.
Annals of the New York Academy of Sciences 1996;805():558-62.
1996: Marc Laburthe; Alain Couvineau; P Gaudin; JJ Maoret; Christiane Rouyer-Fessard; Pascal Nicole
Receptors for VIP, PACAP, secretin, GRF, glucagon, GLP-1, and other members of their new family of G protein-linked receptors: structure-function relationship with special reference to the human VIP-1 receptor.
Annals of the New York Academy of Sciences 1996;805():94-109; discussion 110-1.
1996: Alain Couvineau; Christiane Rouyer-Fessard; JJ Maoret; P Gaudin; Pascal Nicole; Marc Laburthe
Vasoactive intestinal peptide (VIP)1 receptor. Three nonadjacent amino acids are responsible for species selectivity with respect to recognition of peptide histidine isoleucineamide.
The Journal of biological chemistry 1996;271(22):12795-800.
1996: P Gaudin; Alain Couvineau; JJ Maoret; Christiane Rouyer-Fessard; Marc Laburthe
Stable expression of the recombinant human VIP1 receptor in clonal Chinese hamster ovary cells: pharmacological, functional and molecular properties.
European journal of pharmacology 1996;302(1-3):207-14.
1996: Alain Couvineau; C Fabre; P Gaudin; JJ Maoret; Marc Laburthe
Mutagenesis of N-glycosylation sites in the human vasoactive intestinal peptide 1 receptor. Evidence that asparagine 58 or 69 is crucial for correct delivery of the receptor to plasma membrane.
Biochemistry 1996;35(6):1745-52.
1996: Thierry Voisin; AM Lorinet; JJ Maoret; Alain Couvineau; Marc Laburthe
G alpha i RNA antisense expression demonstrates the exclusive coupling of peptide YY receptors to G(i)2 proteins in renal proximal tubule cells.
The Journal of biological chemistry 1996;271(1):574-80.
1995: Eric Ogier-Denis; Chantal Bauvy; Alain Couvineau; Daniela De Stefanis; Ciro Isidoro; Patrice Codogno
Localization and processing of glycosylphosphatidylinositol anchored cathepsin D.
Biochemical and biophysical research communications 1995;211(3):935-42.
1995: P Gaudin; Alain Couvineau; JJ Maoret; Christiane Rouyer-Fessard; Marc Laburthe
Mutational analysis of cysteine residues within the extracellular domains of the human vasoactive intestinal peptide (VIP) 1 receptor identifies seven mutants that are defective in VIP binding.
Biochemical and biophysical research communications 1995;211(3):901-8.
1995: Eric Ogier-Denis; Alain Couvineau; JJ Maoret; J J Houri; Chantal Bauvy; Daniela De Stefanis; Ciro Isidoro; Marc Laburthe; Patrice Codogno
A heterotrimeric Gi3-protein controls autophagic sequestration in the human colon cancer cell line HT-29.
The Journal of biological chemistry 1995;270(1):13-6.
1995: Alain Couvineau; P Gaudin; JJ Maoret; Christiane Rouyer-Fessard; Pascal Nicole; Marc Laburthe
Highly conserved aspartate 68, tryptophane 73 and glycine 109 in the N-terminal extracellular domain of the human VIP receptor are essential for its ability to bind VIP.
Biochemical and biophysical research communications 1995;206(1):246-52.
1994: N Rodriguez-Henche; Luis G Guijarro; Alain Couvineau; Isabel Carrero; Eduardo Arilla; Marc Laburthe; Juan Prieto
G proteins in rat liver proliferation during cholestasis.
Hepatology (Baltimore, Md.) 1994;20(4 Pt 1):1041-7.
1994: D Darmoul; Thierry Voisin; Alain Couvineau; Christiane Rouyer-Fessard; R Salomon; Y Wang; Dallas M Swallow; Marc Laburthe
Regional expression of epithelial dipeptidyl peptidase IV in the human intestines.
Biochemical and biophysical research communications 1994;203(2):1224-9.
1994: JJ Maoret; D Pospaï; Christiane Rouyer-Fessard; Alain Couvineau; Christian L Laboisse; Thierry Voisin; Marc Laburthe
Neurotensin receptor and its mRNA are expressed in many human colon cancer cell lines but not in normal colonic epithelium: binding studies and RT-PCR experiments.
Biochemical and biophysical research communications 1994;203(1):465-71.
1994: Alain Couvineau; Christiane Rouyer-Fessard; D Darmoul; JJ Maoret; Isabel Carrero; Eric Ogier-Denis; Marc Laburthe
Human intestinal VIP receptor: cloning and functional expression of two cDNA encoding proteins with different N-terminal domains.
Biochemical and biophysical research communications 1994;200(2):769-76.
1994: M Laburthe; Alain Couvineau; B Amiranoff; Thierry Voisin
Receptors for gut regulatory peptides.
Baillière's clinical endocrinology and metabolism 1994;8(1):77-110.
1993: C Fabre; Assou El-Battari; Y Karamanos; Alain Couvineau; R Salomon; Marc Laburthe; Jacques Marvaldi; J Pichon; José Luis
Glycosylation of VIP receptors: a molecular basis for receptor heterogeneity.
Peptides 1993;14(3):483-9.
1993: Philippe Valet; Jean-Michel Senard; J C Devedjian; V Planat; R Salomon; Thierry Voisin; G Drean; Alain Couvineau; Danièle Daviaud; C Denis
Characterization and distribution of alpha 2-adrenergic receptors in the human intestinal mucosa.
The Journal of clinical investigation 1993;91(5):2049-57.
1993: Y Chen; A Fournier; Alain Couvineau; M Laburthe; B Amiranoff
Purification of a galanin receptor from pig brain.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(9):3845-9.
1993: R Salomon; Alain Couvineau; Christiane Rouyer-Fessard; Thierry Voisin; D Lavallée; A Blais; D Darmoul; Marc Laburthe
Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
The American journal of physiology 1993;264(2 Pt 1):E294-300.
1992: Luis G Guijarro; Alain Couvineau; M S Rodriguez-Pena; María G Juarranz; N Rodriguez-Henche; Eduardo Arilla; Marc Laburthe; Juan Prieto
Vasoactive intestinal peptide receptors in rat liver after partial hepatectomy.
The Biochemical journal 1992;285 ( Pt 2)():515-20.
1992: Alain Couvineau; D Darmoul; A Blais; Christiane Rouyer-Fessard; Danièle Daviaud; Thierry Voisin; Hervé Paris; Bruno Rouot; Marc Laburthe
Gs and Gi protein subunits during cell differentiation in intestinal crypt-villus axis: regulation at the mRNA level.
The American journal of physiology 1992;262(6 Pt 1):C1478-84.
1992: Y Chen; Alain Couvineau; M Laburthe; B Amiranoff
Solubilization and molecular characterization of active galanin receptors from rat brain.
Biochemistry 1992;31(8):2415-22.
1991: D Darmoul; Christiane Rouyer-Fessard; A Blais; Thierry Voisin; Catherine Sapin; L Baricault; C Cibert; G Geraud; Alain Couvineau; Marc Laburthe
Dipeptidyl peptidase IV expression in rat jejunal crypt-villus axis is controlled at mRNA level.
The American journal of physiology 1991;261(5 Pt 1):G763-9.
1991: Thierry Voisin; Alain Couvineau; Christiane Rouyer-Fessard; Marc Laburthe
Solubilization and hydrodynamic properties of active peptide YY receptor from rat jejunal crypts. Characterization as a Mr 44,000 glycoprotein.
The Journal of biological chemistry 1991;266(17):10762-7.
1991: Thierry Voisin; Alain Couvineau; Luis G Guijarro; M Laburthe
VIP receptors from porcine liver: high yield solubilization in a GTP-insensitive form.
Life sciences 1991;48(2):135-41.
1990: Alain Couvineau; Thierry Voisin; Luis G Guijarro; Marc Laburthe
Purification of vasoactive intestinal peptide receptor from porcine liver by a newly designed one-step affinity chromatography.
The Journal of biological chemistry 1990;265(22):13386-90.
1990: Alain Couvineau; Christiane Rouyer-Fessard; Thierry Voisin; M Laburthe
Functional and immunological evidence for stable association of solubilized vasoactive-intestinal-peptide receptor and stimulatory guanine-nucleotide-binding protein from rat liver.
European journal of biochemistry / FEBS 1990;187(3):605-9.
1989: Luis G Guijarro; Alain Couvineau; J R Calvo; M Laburthe
Solubilization of active and stable receptors for vasoactive intestinal peptide from rat liver.
Regulatory peptides 1989;25(1):37-50.
1989: J R Calvo; Alain Couvineau; Luis G Guijarro; M Laburthe
Solubilization and hydrodynamic characterization of guanine nucleotide sensitive vasoactive intestinal peptide-receptor complexes from rat intestine.
Biochemistry 1989;28(4):1667-72.
1989: Christiane Rouyer-Fessard; Alain Couvineau; Thierry Voisin; Marc Laburthe
Ac-Tyr1hGRF discriminates between VIP receptors from rat liver and intestinal epithelium.
Life sciences 1989;45(9):829-33.
1987: M Laburthe; Monique Rousset; Christiane Rouyer-Fessard; Alain Couvineau; Isabelle Chantret; G Chevalier; Alain Zweibaum
Development of vasoactive intestinal peptide-responsive adenylate cyclase during enterocytic differentiation of Caco-2 cells in culture. Evidence for an increased receptor level.
The Journal of biological chemistry 1987;262(21):10180-4.
1987: B Amiranoff; A L Servin; Christiane Rouyer-Fessard; Alain Couvineau; K Tatemoto; M Laburthe
Galanin receptors in a hamster pancreatic beta-cell tumor: identification and molecular characterization.
Endocrinology 1987;121(1):284-9.
1987: J C Bozou; Alain Couvineau; Christiane Rouyer-Fessard; M Laburthe; Jean-Pierre Vincent; Patrick Kitabgi
Phorbol ester induces loss of VIP stimulation of adenylate cyclase and VIP-binding sites in HT29 cells.
FEBS letters 1987;211(2):151-4.
1986: Alain Couvineau; B Amiranoff; M Laburthe
Solubilization of the liver vasoactive intestinal peptide receptor. Hydrodynamic characterization and evidence for an association with a functional GTP regulatory protein.
The Journal of biological chemistry 1986;261(31):14482-9.
1986: B Amiranoff; Alain Couvineau; N Vauclin-Jacques; M Laburthe
Gastric inhibitory polypeptide receptor in hamster pancreatic beta cells. Direct cross-linking, solubilization and characterization as a glycoprotein.
European journal of biochemistry / FEBS 1986;159(2):353-8.
1986: M Laburthe; B Chenut; Christiane Rouyer-Fessard; K Tatemoto; Alain Couvineau; A Servin; B Amiranoff
Interaction of peptide YY with rat intestinal epithelial plasma membranes: binding of the radioiodinated peptide.
Endocrinology 1986;118(5):1910-7.
1986: M Laburthe; Alain Couvineau; Christiane Rouyer-Fessard
Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
Molecular pharmacology 1986;29(1):23-7.
1985: Alain Couvineau; Monique Rousset; M Laburthe
Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
The Biochemical journal 1985;231(1):139-43.
1985: M Laburthe; Alain Couvineau; Christiane Rouyer-Fessard; L Moroder
Interaction of PHM, PHI and 24-glutamine PHI with human VIP receptors from colonic epithelium: comparison with rat intestinal receptors.
Life sciences 1985;36(10):991-5.
1984: Alain Couvineau; B Amiranoff; N Vauclin-Jacques; M Laburthe
The GIP receptor on pancreatic beta cell tumor: molecular identification by covalent cross-linking.
Biochemical and biophysical research communications 1984;122(1):283-8.
1984: Alain Couvineau; Christiane Rouyer-Fessard; A Fournier; S St Pierre; R Pipkorn; M Laburthe
Structural requirements for VIP interaction with specific receptors in human and rat intestinal membranes: effect of nine partial sequences.
Biochemical and biophysical research communications 1984;121(2):493-8.